Drug Shortage Report for MAR-VALACYCLOVIR
Report ID | 754 |
Drug Identification Number | 02441586 |
Brand name | MAR-VALACYCLOVIR |
Common or Proper name | MAR-Valacyclovir |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | VALACYCLOVIR |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 Tablet |
ATC code | J05AB |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2017-03-13 |
Actual start date | |
Estimated end date | 2017-10-01 |
Actual end date | 2017-06-01 |
Shortage status | Resolved |
Updated date | 2017-06-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-06-12 | French | Compare |
v4 | 2017-06-12 | English | Compare |
v3 | 2017-03-14 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 5 of 5